Skip to main content

November 2019 Vol 12, No 7

Business, Original Research
The Economic Implications of Hyperkalemia in a Medicaid Managed Care Population
Nihar R. Desai, MD, MPH; Pamala Reed, DrPH, MPH; Paula J. Alvarez, RPh, MBA, MPH; Jeanene Fogli, PhD, RD; Steven D. Woods, PharmD; Mary Kay Owens, RPh, CPh
Stakeholder Perspective
The Impact of Quality Care on a Medicaid Population with Hyperkalemia
Byron C. Scott, MD, MBA
Read More
FDA Approvals
FDA Oncology Update
Read More
Editorial
Predicting Success in Population Health
David B. Nash, MD, MBA
Read More
Business, Original Research
Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia
David Campbell, PharmD, MS; Marlo Blazer, PharmD, BCOP; Lisa Bloudek, PharmD, MS; John Brokars, MS; Dinara Makenbaeva, MD, MBA
Stakeholder Perspective
The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs
James T. Kenney, RPh, MBA
Read More
Industry Trends
Key Trends in Healthcare for 2020 and Beyond
F. Randy Vogenberg, PhD; John Santilli, MBA
Read More

Results 1 - 5 of 5